MDI-403

Overview

MDI-403 is a retinoic acid receptor ( RAR ) agonist with an EC 50 value of less than 1 μM. MDI-403 exhibits significant antiviral activity against SARS-CoV-2, and can dose-dependently inhibit the expression of viral nucleoprotein ( NP ) and reduce the proportion of infected cells. MDI-403 mainly acts during the virus invasion stage. MDI-403 can be used in research on anti-SARS-CoV-2.

Application

Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > RAR/RXR | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-W816575
• CAS No.: 127471-94-7
• Molecular Formula: C29H36O4
• Molecular Weight: 448.59
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source